Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

EWS-FLI1 employs an E2F switch to drive target gene expression.

Schwentner R, Papamarkou T, Kauer MO, Stathopoulos V, Yang F, Bilke S, Meltzer PS, Girolami M, Kovar H.

Nucleic Acids Res. 2015 Mar 11;43(5):2780-9. doi: 10.1093/nar/gkv123. Epub 2015 Feb 20.

2.

E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.

Wei WY, Yan LH, Wang XT, Li L, Cao WL, Zhang XS, Zhan ZX, Yu H, Xie YB, Xiao Q.

World J Gastroenterol. 2015 Jan 14;21(2):491-501. doi: 10.3748/wjg.v21.i2.491.

3.

Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling.

Morales LD, Casillas Pavón EA, Shin JW, Garcia A, Capetillo M, Kim DJ, Lieman JH.

PLoS One. 2014 May 8;9(5):e97104. doi: 10.1371/journal.pone.0097104. eCollection 2014.

4.

Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.

Kunter I, Erdal E, Nart D, Yilmaz F, Karademir S, Sagol O, Atabey N.

Oncol Rep. 2014 Feb;31(2):573-80. doi: 10.3892/or.2013.2932. Epub 2013 Dec 16.

5.

The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage.

Feldstein O, Nizri T, Doniger T, Jacob J, Rechavi G, Ginsberg D.

Mol Cancer. 2013 Oct 29;12(1):131. doi: 10.1186/1476-4598-12-131.

6.
7.

Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature.

Condiotti R, Goldenberg D, Giladi H, Schnitzer-Perlman T, Waddington SN, Buckley SM, Heim D, Cheung W, Themis M, Coutelle C, Simerzin A, Osejindu E, Wege H, Themis M, Galun E.

Mol Ther. 2014 Jan;22(1):59-68. doi: 10.1038/mt.2013.193. Epub 2013 Aug 28.

8.

Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.

Su S, Minges JT, Grossman G, Blackwelder AJ, Mohler JL, Wilson EM.

J Biol Chem. 2013 Aug 23;288(34):24809-24. doi: 10.1074/jbc.M113.468579. Epub 2013 Jul 12.

9.

Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.

Gulappa T, Reddy RS, Suman S, Nyakeriga AM, Damodaran C.

Cancer Lett. 2013 Sep 1;337(2):177-83. doi: 10.1016/j.canlet.2013.05.014. Epub 2013 May 16.

10.

Deciphering the retinoblastoma protein phosphorylation code.

Rubin SM.

Trends Biochem Sci. 2013 Jan;38(1):12-9. doi: 10.1016/j.tibs.2012.10.007. Epub 2012 Dec 3. Review.

11.

Angiotensin II: tapping the cell cycle machinery to kill endothelial cells.

O'Reilly MA.

Am J Physiol Lung Cell Mol Physiol. 2012 Oct 1;303(7):L575-6. doi: 10.1152/ajplung.00260.2012. Epub 2012 Aug 10. No abstract available.

12.

Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4.

Kim YC, Day RM.

Am J Physiol Lung Cell Mol Physiol. 2012 Aug 1;303(3):L228-38. doi: 10.1152/ajplung.00087.2012. Epub 2012 Jun 1.

13.

Autophagy regulation in cancer development and therapy.

White EJ, Martin V, Liu JL, Klein SR, Piya S, Gomez-Manzano C, Fueyo J, Jiang H.

Am J Cancer Res. 2011;1(3):362-372. Epub 2010 Jan 25.

14.

Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Taylor JR, Lehmann BD, Chappell WH, Abrams SL, Steelman LS, McCubrey JA.

Oncotarget. 2011 Aug;2(8):610-26.

15.

Transgenic and knockout mice models to reveal the functions of tumor suppressor genes.

Taneja P, Zhu S, Maglic D, Fry EA, Kendig RD, Inoue K.

Clin Med Insights Oncol. 2011;5:235-57. doi: 10.4137/CMO.S7516. Epub 2011 Jul 28.

16.

CGGBP1 regulates cell cycle in cancer cells.

Singh U, Roswall P, Uhrbom L, Westermark B.

BMC Mol Biol. 2011 Jul 7;12:28. doi: 10.1186/1471-2199-12-28.

17.

p21-activated kinase 1: PAK'ed with potential.

Ong CC, Jubb AM, Zhou W, Haverty PM, Harris AL, Belvin M, Friedman LS, Koeppen H, Hoeflich KP.

Oncotarget. 2011 Jun;2(6):491-6. Review.

18.

Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.

Ong CC, Jubb AM, Haverty PM, Zhou W, Tran V, Truong T, Turley H, O'Brien T, Vucic D, Harris AL, Belvin M, Friedman LS, Blackwood EM, Koeppen H, Hoeflich KP.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7177-82. doi: 10.1073/pnas.1103350108. Epub 2011 Apr 11.

19.

RB1, development, and cancer.

Chinnam M, Goodrich DW.

Curr Top Dev Biol. 2011;94:129-69. doi: 10.1016/B978-0-12-380916-2.00005-X. Review.

20.

Comparison of proliferation and genomic instability responses to WRN silencing in hematopoietic HL60 and TK6 cells.

Ren X, Lim S, Ji Z, Yuh J, Peng V, Smith MT, Zhang L.

PLoS One. 2011 Jan 18;6(1):e14546. doi: 10.1371/journal.pone.0014546.

Supplemental Content

Support Center